Profile data is unavailable for this security.
About the company
Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.
- Revenue in USD (TTM)2.73bn
- Net income in USD183.35m
- Incorporated1947
- Employees11.50k
- LocationRevvity Inc940 Winter StreetWALTHAM 02451United StatesUSA
- Phone+1 (781) 663-5791
- Websitehttps://www.revvity.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Olink Holding AB (publ) - ADR | 170.89m | -33.70m | 2.98bn | 707.00 | -- | -- | -- | 17.43 | -0.2704 | -0.2704 | 1.37 | -- | 0.3099 | 0.9632 | 5.40 | 241,712.90 | -6.11 | -- | -6.54 | -- | 66.88 | -- | -19.72 | -- | 3.91 | -- | 0.0537 | -- | 21.27 | -- | -145.90 | -- | -- | -- |
| Badger Meter Inc | 740.77m | 102.31m | 5.80bn | 2.14k | 56.81 | 10.82 | 44.09 | 7.83 | 3.47 | 3.47 | 25.13 | 18.22 | 1.08 | 3.07 | 8.39 | 346,154.70 | 14.86 | 12.26 | 18.17 | 14.60 | 39.26 | 39.38 | 13.81 | 12.06 | 2.30 | -- | 0.00 | 36.36 | 24.40 | 10.16 | 39.25 | 27.22 | 6.79 | 12.07 |
| Vontier Corp | 3.07bn | 430.90m | 6.14bn | 8.00k | 14.38 | 6.24 | 11.04 | 2.00 | 2.77 | 2.77 | 19.73 | 6.37 | 0.7163 | 5.03 | 6.21 | 384,325.00 | 10.04 | 10.80 | 12.63 | 14.04 | 47.17 | 44.62 | 14.01 | 13.36 | 1.23 | 6.23 | 0.6935 | 2.24 | -2.80 | 3.03 | -6.08 | -0.5018 | 7.23 | -- |
| Cognex Corp | 847.22m | 99.64m | 8.21bn | 2.99k | 83.24 | 5.52 | 65.88 | 9.70 | 0.5749 | 0.5749 | 4.90 | 8.68 | 0.425 | 1.66 | 5.72 | 283,161.80 | 5.00 | 10.63 | 5.56 | 11.56 | 70.75 | 72.97 | 11.76 | 22.38 | 2.61 | -- | 0.00 | 57.03 | -16.75 | 0.7624 | -47.46 | -13.24 | -9.06 | 9.03 |
| Bio Rad Laboratories Inc | 2.61bn | -322.37m | 8.31bn | 8.03k | -- | 0.926 | -- | 3.19 | -10.36 | -10.36 | 89.91 | 317.32 | 0.1983 | 1.58 | 5.52 | 324,438.10 | -2.45 | 9.08 | -2.56 | 9.60 | 53.53 | 55.55 | -12.37 | 41.97 | 4.89 | 0.4496 | 0.117 | 0.00 | -4.67 | 3.13 | 82.43 | -- | 3.83 | -- |
| MKS Instruments Inc | 3.70bn | -1.78bn | 8.62bn | 10.00k | -- | 3.55 | -- | 2.33 | -26.71 | -26.71 | 55.13 | 36.13 | 0.3641 | 1.94 | 6.07 | 369,500.00 | -17.58 | -1.60 | -19.08 | -1.75 | 46.60 | 44.95 | -48.28 | -3.25 | 2.34 | 1.45 | 0.6617 | -- | 2.11 | 11.78 | -652.85 | -- | 6.69 | 2.44 |
| Bruker Corp | 3.00bn | 401.60m | 10.91bn | 9.71k | 27.34 | 7.71 | 20.74 | 3.64 | 2.75 | 2.75 | 20.44 | 9.74 | 0.7257 | 1.55 | 6.34 | 309,148.00 | 9.71 | 8.38 | 13.45 | 11.40 | 50.43 | 49.85 | 13.38 | 11.39 | 0.9132 | 179.75 | 0.4872 | 9.81 | 17.14 | 9.36 | 44.03 | 18.91 | 16.79 | 4.56 |
| Revvity Inc | 2.73bn | 183.35m | 13.60bn | 11.50k | 74.65 | 1.73 | 22.16 | 4.99 | 1.48 | 1.21 | 21.96 | 63.54 | 0.1942 | 2.87 | 4.64 | 237,011.00 | 1.31 | 4.76 | 1.46 | 5.39 | 55.52 | 57.19 | 6.73 | 15.34 | 1.92 | 6.11 | 0.3307 | 6.52 | -16.95 | -0.1982 | -64.99 | -5.28 | -2.69 | 0.00 |
| Avantor Inc | 6.87bn | 260.00m | 16.97bn | 14.50k | 65.32 | 3.18 | 25.69 | 2.47 | 0.3826 | 0.3826 | 10.12 | 7.86 | 0.525 | 5.32 | 5.71 | 473,565.50 | 1.99 | 2.97 | 2.26 | 3.35 | 33.63 | 33.44 | 3.79 | 5.06 | 1.05 | 3.03 | 0.4994 | 0.00 | -7.26 | 3.51 | -51.52 | -- | 31.17 | -- |
| Illumina Inc | 4.49bn | -1.29bn | 17.69bn | 10.59k | -- | 3.08 | -- | 3.94 | -8.15 | -8.15 | 28.39 | 36.06 | 0.4112 | 2.97 | 6.75 | 424,268.20 | -11.80 | -6.20 | -14.21 | -7.28 | 61.36 | 66.39 | -28.69 | -15.48 | 1.36 | -- | 0.2063 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
| Waters Corp | 2.91bn | 603.51m | 21.11bn | 7.90k | 34.94 | 16.80 | 26.83 | 7.26 | 10.19 | 10.19 | 49.09 | 21.19 | 0.7443 | 2.26 | 4.44 | 368,174.80 | 15.44 | 19.77 | 19.58 | 25.29 | 59.68 | 58.45 | 20.75 | 23.38 | 1.30 | 8.46 | 0.6207 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
| Veralto Corp | 5.04bn | 798.00m | 24.34bn | 16.00k | 30.51 | 16.42 | 27.53 | 4.83 | 3.23 | 3.23 | 20.42 | 6.00 | 0.9556 | 6.40 | 6.17 | 315,125.00 | 15.12 | -- | 19.09 | -- | 58.31 | -- | 15.83 | -- | 1.56 | 19.98 | 0.6376 | -- | 3.10 | -- | -0.7101 | -- | -- | -- |
| Fortive Corp | 6.13bn | 899.60m | 27.16bn | 18.00k | 30.49 | 2.59 | 19.68 | 4.43 | 2.53 | 2.53 | 17.24 | 29.76 | 0.3678 | 4.31 | 6.10 | 340,505.60 | 5.40 | 4.90 | 6.22 | 6.00 | 59.55 | 57.15 | 14.68 | 15.01 | 1.17 | 8.67 | 0.2733 | 12.88 | 4.11 | 9.80 | 14.65 | 14.69 | -0.8146 | 0.7043 |
Data as of May 18 2024. Currency figures normalised to Revvity Inc's reporting currency: US Dollar USD
57.99%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 15.64m | 12.66% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 13.57m | 10.98% |
| Select Equity Group LPas of 31 Dec 2023 | 11.27m | 9.13% |
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2023 | 7.67m | 6.21% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 6.11m | 4.95% |
| Janus Henderson Investors US LLCas of 31 Dec 2023 | 5.43m | 4.40% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 5.18m | 4.20% |
| Geode Capital Management LLCas of 31 Dec 2023 | 2.70m | 2.19% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 31 Mar 2024 | 2.13m | 1.72% |
| Independent Franchise Partners LLPas of 31 Dec 2023 | 1.93m | 1.56% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
